Montag A & Associates Inc Embecta Corp. Transaction History

Montag A & Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$23.07 - $32.77 $13,634 - $19,367	-591 Reduced 66.63%	296 $8,000
Q4 2022 Feb 02, 2023	SELL	$25.29 - $35.48 $3,515 - $4,931	-139 Reduced 13.55%	887 $22,000
Q3 2022 Nov 09, 2022	SELL	$24.0 - $33.42 $12,720 - $17,712	-530 Reduced 34.06%	1,026 $30,000
Q2 2022 Aug 10, 2022	BUY	$24.78 - $33.36 $38,557 - $51,908	1,556 New	1,556 $39,000

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Montag A & Associates Inc with notifications on news.